BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND DUX4L1, DUX4, P0CJ90, P0CJ89, P0CJ88, P0CJ86, P0CJ85, 22947 AND Diagnosis
4 results:

  • 1. Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group.
    Brahmi M; Gaspar N; Gantzer J; Toulmonde M; Boudou-Rouquette P; Bompas E; Firmin N; Valentin T; Cancel M; Duffaud F; Bertucci F; Perrin C; Dufresne A; Marec-Bérard P; Jean-Denis M; Ray-Coquard I; Le Loarer F; Pierron G; Tirode F; Blay JY; Watson S
    Cancer Med; 2023 Apr; 12(7):7801-7807. PubMed ID: 36537582
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Undifferentiated round cell sarcomas with CIC-dux4 gene fusion: expanding the clinical spectrum.
    Brčić I; Brodowicz T; Cerroni L; Kashofer K; Serbanescu GL; Kasseroler MT; Amann G; Scheipl S; Szkandera J; Leithner A; Liegl-Atzwanger B
    Pathology; 2020 Feb; 52(2):236-242. PubMed ID: 31870501
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. "Cyst" on the forearm of a 28-year-old female: Case report of a CIC-rearranged sarcoma.
    Lehane F; Tsikleas G; Bettington A; Limarporn K; Wilkinson L; Lehane K
    J Cutan Pathol; 2019 Aug; 46(8):599-602. PubMed ID: 30989672
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.
    Karanian-Philippe M; Velasco V; Longy M; Floquet A; Arnould L; Coindre JM; Le Naoures-Méar C; Averous G; Guyon F; MacGrogan G; Croce S
    Am J Surg Pathol; 2015 Sep; 39(9):1197-205. PubMed ID: 26135561
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.